APA aipamena

Ratner, R., Nauck, M., Kapitza, C., Asnaghi, V., Boldrin, M., & Balena, R. (2010). Safety and tolerability of high doses of taspoglutide, a once-weekly human GLP-1 analogue, in diabetic patients treated with metformin: A randomized double-blind placebo-controlled study1,2. Blackwell Publishing Ltd.

Chicago Style aipamena

Ratner, R., M. Nauck, C. Kapitza, V. Asnaghi, M. Boldrin, and R. Balena. Safety and Tolerability of High Doses of Taspoglutide, a Once-weekly Human GLP-1 Analogue, in Diabetic Patients Treated With Metformin: A Randomized Double-blind Placebo-controlled Study1,2. Blackwell Publishing Ltd, 2010.

MLA aipamena

Ratner, R., et al. Safety and Tolerability of High Doses of Taspoglutide, a Once-weekly Human GLP-1 Analogue, in Diabetic Patients Treated With Metformin: A Randomized Double-blind Placebo-controlled Study1,2. Blackwell Publishing Ltd, 2010.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.